OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析

◆英語タイトル:OBI Pharma Inc (4174) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH429535FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a cancer vaccine for epithelial cancers other than breast and ovarian cancer. It also develops active immunotherapies intended for the treatment of various lung, prostate, pancreatic, stomach and ovarian cancers. OBI Pharma develops its pipeline products through its carbohydrate synthesis discovery platform. The company has collaboration with research institutes including cancer centers to enhance its pipeline products. It operates in the US, Taiwan and China. OBI Pharma is headquartered in Taipei, Taiwan.

OBI Pharma Inc Key Recent Developments

Jan 11,2021: OBI Pharma, Inc. to Present at the 39th J.P. Morgan Healthcare Conference
Sep 28,2020: Taiwan Hao Ding held a major news press conference

This comprehensive SWOT profile of OBI Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OBI Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

OBI Pharma Inc – Key Information
OBI Pharma Inc – Overview
OBI Pharma Inc – Key Employees
OBI Pharma Inc – Key Employee Biographies
OBI Pharma Inc – Key Operational Heads
OBI Pharma Inc – Major Products and Services
OBI Pharma Inc – History
OBI Pharma Inc – Company Statement
OBI Pharma Inc – Locations And Subsidiaries
OBI Pharma Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

OBI Pharma Inc – Business Description
OBI Pharma Inc – Corporate Strategy
OBI Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
OBI Pharma Inc – Strengths
OBI Pharma Inc – Weaknesses
OBI Pharma Inc – Opportunities
OBI Pharma Inc – Threats
OBI Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

OBI Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

OBI Pharma Inc, Key Information
OBI Pharma Inc, Key Ratios
OBI Pharma Inc, Share Data
OBI Pharma Inc, Major Products and Services
OBI Pharma Inc, History
OBI Pharma Inc, Key Employees
OBI Pharma Inc, Key Employee Biographies
OBI Pharma Inc, Key Operational Heads
OBI Pharma Inc, Other Locations
OBI Pharma Inc, Subsidiaries
OBI Pharma Inc, Key Competitors
OBI Pharma Inc, SWOT Analysis
OBI Pharma Inc, Ratios based on current share price
OBI Pharma Inc, Annual Ratios
OBI Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • KION GROUP AG:企業の戦略・SWOT・財務情報
    KION GROUP AG - Strategy, SWOT and Corporate Finance Report Summary KION GROUP AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Samsung Heavy Industries Co Ltd:戦略・SWOT・企業財務分析
    Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Zecotek Photonics Inc (ZMS):医療機器:M&Aディール及び事業提携情報
    Summary Zecotek Photonics Inc. (Zecotek) is a photonics technology company that focuses on developing advanced materials and integrated optoelectronic devices for optical precision surgery, high resolution medical imaging and biopharmaceutical research. It develops and sells scintillation crystals, …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Ineos Group AG:石油・ガス:M&Aディール及び事業提携情報
    Summary Ineos Group AG (Ineos), a subsidiary of INEOS Group Holdings SA, is a chemical manufacturing company. It manufactures and sells petrochemicals, specialty chemicals and oil products. The company’s products include ammonia, nitric acid, sea salt, esters, bio fuel, sulphuric acid, amino resin, …
  • VWR International LLC:医療機器:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Tata Motors Ltd (TATAMOTORS):企業の財務・戦略的SWOT分析
    Tata Motors Ltd (TATAMOTORS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fairfield Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Fairfield Energy Ltd (Fairfield Energy), a subsidiary of Decom Energy Ltd is an oil and gas company that offers oil and gas decommissioning services. The company acquires and develops hydrocarbon properties. It acquires and operates marginal fields in the UK continental shelf. Fairfield Ener …
  • Waagner-Biro Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Petrolia SE (PDR):企業の財務・戦略的SWOT分析
    Summary Petrolia SE (Petrolia), formerly Petrolia E&P Holdings SE is an oil and gas company that offers well technology solutions. The company operates through two segments such as exploration and production (E&P), and oil service segments. Its E&P’s segment seeks to maximise field potential through …
  • NIBE Industrier AB:企業のM&A・事業提携・投資動向
    NIBE Industrier AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIBE Industrier AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Rousselot S.A.S.:企業の戦略・SWOT・財務情報
    Rousselot S.A.S. - Strategy, SWOT and Corporate Finance Report Summary Rousselot S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fnm Spa:企業の戦略・SWOT・財務分析
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Osaka University:製薬・医療:M&Aディール及び事業提携情報
    Summary Osaka University (OU) is an educational university that provides undergraduate and graduate courses. The university provides courses in dentistry, economics, engineering, engineering science, foreign studies, human sciences, law and politics, medicine, information science and technology, lan …
  • Bharat Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • One Way Liver SL:医療機器:M&Aディール及び事業提携情報
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that develops, discovers, and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver that is a serum based test used for steatosis and NASH diagno …
  • RUAG Holding AG:企業の戦略・SWOT・財務情報
    RUAG Holding AG - Strategy, SWOT and Corporate Finance Report Summary RUAG Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Far East Hotels And Entertainment Limited
    Far East Hotels And Entertainment Limited - Strategy, SWOT and Corporate Finance Report Summary Far East Hotels And Entertainment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆